EGFR and central nervous system cancer: Several studies have revealed that mutations in the epidermal growth factor receptor (EGFR) gene were associated with shorter intervals between relapses and a poorer survival rate for gliomas, and that EGFR expression is correlated with tumor progression (6,7).